ReviewFrontiers in immunology2026
Macrophages dynamically integrate neuro-immune-microbial network signals: their role in gastrointestinal motility disorders and targeting potential.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastrointestinal motility disorders are pathologically characterized by dysregulation of the tripartite network comprising the intestinal immune system, the enteric nervous system, and the gut microbiota. Targeted medicines that target important nodes in this network are desperately needed, and macrophages-tissue-resident immune cells with a high degree of plasticity-are showing promise as therapeutic targets. Through functional polarization, macrophages serve a key role in controlling intestinal inflammation and motility by integrating various signals from immune cells, pathogens, and neurons. According to new research, macrophages have two roles in gastrointestinal motility disorders: on the one hand, abnormal polarization can lead to immunological dysregulation and neuronal damage, which exacerbates motility dysfunction; on the other hand, certain subsets of macrophages aid in tissue repair and homeostasis. A thorough study that methodically outlines the pathogenic processes and therapeutic possibilities of macrophages in gastrointestinal motility disorders is still absent, despite recent advancements. In addition to evaluating new treatment approaches that target macrophage polarization, phagocytic function, and neuro-immune interaction, this review summarizes the unique mechanistic functions of macrophages in situations such postoperative ileus, constipation, and disorders of gut-brain interactions. In addition to offering theoretical insights and fresh approaches for precision intervention in gastrointestinal motility disorders, our goals are to expand on the present knowledge of the gut neuro-immune-microbiota regulating network.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.